rinary tract symptoms and related factors following Piver III radical hysterectomy for cervical cancer.
[156]Yang, Y.; Sun, J.; Wang, Z.; Fang, J.; Yu, Q.; Han, B.; Cang, S.; Chen, G.; Mei, X.; Yang, Z.; Ma, R.; Bi, M.; Ren, X.; Zhou, J.; Li, B.; Zhou, H.; Wang, S.; Xu, W.; Peng, B.; Zhang, L.MHC-II antigen presentation pathway as a predictive biomarker for sintilimab plus chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC).